OLMA - Olema Pharmaceuticals, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$41.88
DETAILS
HIGH:
$48.00
LOW:
$35.00
MEDIAN:
$41.50
CONSENSUS:
$41.88
UPSIDE:
206.14%
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | 0 | 0 | 0 | 0 | 0 | 0.0 | 0.0 | 0.0 |
| Gross Profit | 0 | 0 | 0 | 0 | 0 | (0.0) | (0.0) | (0.0) |
| Operating Expenses | ||||||||
| R&D Expenses | 157.7 | 124.5 | 86.1 | 82.3 | 51.1 | 13.7 | 3.9 | 1.7 |
| SG&A Expenses | 21.0 | 17.7 | 18.8 | 24.7 | 20.4 | 7.8 | 0.4 | 0.4 |
| Other Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses | 178.7 | 142.3 | 105.0 | 107.0 | 71.5 | 21.5 | 4.3 | 2.1 |
| Operating Income | ||||||||
| Operating Income | (178.7) | (142.3) | (105.0) | (107.0) | (71.5) | (21.5) | (4.3) | (2.1) |
| Interest Expense | 0 | 0 | – | 0 | – | 0.7 | – | 0.0 |
| Interest Income | 16.2 | 12.7 | 8.3 | 2.2 | 0.4 | 0.1 | 0.0 | 0.0 |
| Profitability | ||||||||
| EBITDA | (178.2) | (141.9) | (104.6) | (106.6) | (71.3) | (21.5) | (4.3) | (2.2) |
| EBIT | (178.7) | (142.3) | (105.0) | (107.0) | (71.5) | (21.5) | (4.3) | (2.1) |
| Income Before Tax | (162.5) | (129.5) | (96.7) | (104.8) | (71.1) | (22.1) | (4.3) | (2.2) |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income | (162.5) | (129.5) | (96.7) | (104.8) | (71.1) | (22.1) | (4.3) | (2.2) |
| Per Share Data | ||||||||
| EPS (Basic) | -1.87 | -2.20 | -2.14 | -2.62 | -1.79 | -0.58 | -0.11 | -0.16 |
| EPS (Diluted) | -1.87 | -2.20 | -2.14 | -2.62 | -1.79 | -0.58 | -0.11 | -0.16 |
| Shares Outstanding | 87.0 | 58.7 | 45.2 | 40.0 | 39.5 | 39.3 | 40.2 | 14.1 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Current Assets | ||||||||
| Cash & Cash Equivalents | 48.3 | 139.5 | 68.5 | 23.7 | 13.8 | 338.5 | 0.1 | 3.1 |
| Short-Term Investments | 457.1 | 294.6 | 193.3 | 180.7 | 273.4 | 0 | 0 | 0 |
| Net Receivables | 4.1 | 2.1 | 0.7 | 0.3 | 0.1 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 6.0 | 0.4 | 1.7 | 1.5 | 0 | 0.6 | 0.0 | 0.1 |
| Total Current Assets | 515.5 | 438.5 | 266.5 | 208.9 | 290.7 | 342.1 | 0.1 | 3.2 |
| Non-Current Assets | ||||||||
| Property, Plant & Equipment | 1.1 | 2.1 | 3.3 | 4.0 | 4.7 | 0.1 | 0.0 | 0.0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0.7 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 16.8 | 9.8 | 7.2 | 2.8 | 0.5 | 0.5 | 0.0 | 0.0 |
| Total Non-Current Assets | 18.0 | 12.5 | 10.4 | 6.7 | 5.3 | 0.6 | 0.0 | 0.0 |
| Total Assets | 533.4 | 451.0 | 276.9 | 215.6 | 295.9 | 342.7 | 0.1 | 3.3 |
| Current Liabilities | ||||||||
| Account Payables | 9.3 | 4.5 | 2.7 | 0.4 | 0.0 | 0.7 | 0.9 | 0.1 |
| Short-Term Debt | 1.1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 32.0 | 0 | 5.5 | 4.6 | 4.0 | 0.4 | 0.4 | 0.1 |
| Total Current Liabilities | 51.8 | 41.8 | 21.6 | 16.5 | 9.0 | 4.6 | 1.4 | 0.2 |
| Non-Current Liabilities | ||||||||
| Long-Term Debt | 0.1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 3 | 0 | 0 | 0 | 0 | 0 | 9.3 | 9.3 |
| Total Non-Current Liabilities | 3.1 | 0.3 | 1.4 | 1.6 | 2.4 | 0 | 9.3 | 9.3 |
| Total Liabilities | 54.9 | 42.0 | 23.1 | 18.1 | 11.4 | 4.6 | 10.7 | 9.5 |
| Stockholders' Equity | ||||||||
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0 | 0.0 |
| Retained Earnings | (597.6) | (435.1) | (305.6) | (209.0) | (104.2) | (33.1) | (10.8) | (6.4) |
| Accumulated Other Comprehensive Income | 0.6 | 0.1 | 0.3 | (1.8) | (0.1) | 0 | (0.1) | (0.1) |
| Total Stockholders' Equity | 478.6 | 409.0 | 253.9 | 197.5 | 284.6 | 338.1 | (10.6) | (6.3) |
| Total Liabilities & Equity | 533.4 | 451.0 | 276.9 | 215.6 | 295.9 | 342.7 | 0.1 | 3.3 |
| Debt Metrics | ||||||||
| Total Debt | 1.2 | 1.4 | 2.4 | 2.6 | 3.3 | 0 | 0 | 0 |
| Net Debt | (47.1) | (138.1) | (66.1) | (21.1) | (10.5) | (338.5) | (0.1) | (3.1) |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | (162.5) | (129.5) | (96.7) | (104.8) | (71.1) | (22.1) | (4.3) | (2.2) |
| Depreciation & Amortization | 0.5 | 0.4 | 0.4 | 1.7 | 1.7 | 0.0 | 0.0 | 0.0 |
| Stock-Based Compensation | 17.6 | 22.6 | 17.3 | 0 | 0 | 3.1 | 0 | 0.0 |
| Change in Working Capital | 2.8 | 9.2 | (0.6) | 3.0 | 2.8 | (1.5) | 1.2 | (0.1) |
| Other Non-Cash Items | (5.1) | (7.0) | (4.1) | 18.0 | 15.9 | 0.6 | (0.0) | 0.1 |
| Operating Cash Flow | (146.7) | (104.4) | (83.7) | (82.1) | (50.7) | (19.9) | (3.1) | (2.2) |
| Investing Activities | ||||||||
| Capital Expenditure | 0 | (0.2) | 0 | (0.4) | (1.6) | (0.1) | 0 | 0 |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | (500.7) | (395.0) | (255.6) | (213.7) | (487.0) | 0 | 0 | 0 |
| Sales/Maturities of Investments | 345.0 | 301.6 | 250.8 | 305.5 | 213.1 | 0 | 0 | 0 |
| Other Investing Activities | 0 | 0 | 0.0 | 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | (155.8) | (93.5) | (4.9) | 91.5 | (275.4) | (0.1) | 0 | 0 |
| Financing Activities | ||||||||
| Net Debt Issuance | 3 | 0 | 0 | 0 | 0 | 3.1 | 0 | 0.3 |
| Stock Repurchased | 0 | 0 | 0 | 0 | 0 | (2.3) | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0 | 2.5 | 3.7 | 0 | 0 | 0 | 0 | 4.9 |
| Financing Cash Flow | 211.3 | 268.8 | 133.4 | 0.5 | 1.4 | 358.4 | 0 | 5.3 |
| Cash Position | ||||||||
| Net Change in Cash | (91.2) | 70.9 | 44.8 | 9.9 | (324.7) | 338.5 | (3.1) | 3.1 |
| Cash at Beginning | 139.5 | 68.5 | 23.7 | 13.8 | 338.5 | 0.1 | 3.1 | 0.1 |
| Cash at End | 48.3 | 139.5 | 68.5 | 23.7 | 13.8 | 338.5 | 0.1 | 3.1 |
| Free Cash Flow | (146.7) | (104.5) | (83.7) | (82.4) | (52.3) | (19.9) | (3.1) | (2.2) |
| Key Metrics | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 0 | 0 | 0 | 0 | 0 | (0.0) | (0.0) | (0.0) |
| Operating Income | (178.7) | (142.3) | (105.0) | (107.0) | (71.5) | (21.5) | (4.3) | (2.1) |
| Net Income | (162.5) | (129.5) | (96.7) | (104.8) | (71.1) | (22.1) | (4.3) | (2.2) |
| EPS (Diluted) | -1.87 | -2.20 | -2.14 | -2.62 | -1.79 | -0.58 | -0.11 | -0.16 |
| Balance Sheet | ||||||||
| Cash & Equivalents | 48.3 | 139.5 | 68.5 | 23.7 | 13.8 | 338.5 | 0.1 | 3.1 |
| Total Assets | 533.4 | 451.0 | 276.9 | 215.6 | 295.9 | 342.7 | 0.1 | 3.3 |
| Total Debt | 1.2 | 1.4 | 2.4 | 2.6 | 3.3 | 0 | 0 | 0 |
| Stockholders' Equity | 478.6 | 409.0 | 253.9 | 197.5 | 284.6 | 338.1 | (10.6) | (6.3) |
| Cash Flow | ||||||||
| Operating Cash Flow | (146.7) | (104.4) | (83.7) | (82.1) | (50.7) | (19.9) | (3.1) | (2.2) |
| Capital Expenditure | 0 | (0.2) | 0 | (0.4) | (1.6) | (0.1) | 0 | 0 |
| Free Cash Flow | (146.7) | (104.5) | (83.7) | (82.4) | (52.3) | (19.9) | (3.1) | (2.2) |